| Closed |
SWOG-8691 (INT-0073) |
(INT-0073), A Randomized Comparison of Deoxycoformycin Versus Alpha-Interferon in Previously Untreated Patients With Hairy Cell Leukemia |
12/15/1986 |
10/1/1991 |
100% |
|
Published
|
| Closed |
SWOG-8917 |
5-Fluorouracil, Leucovorin and Roferon-A® in Advanced Colorectal Cancer, Phase II Pilot |
12/1/1989 |
2/15/1992 |
100% |
|
Published
|
| Closed |
SWOG-8017 |
5-FU, Adriamycin, Streptozotocin and Cyclophosphamide (FAC-S) in the Treatment of Metastatic Carcinoid Tumors |
7/7/1980 |
1/19/1984 |
|
|
Published
|
| Closed |
SWOG-8894 (INT-0105) (EST-2889) |
A Comparison of Bilateral Orchiectomy with or without Flutamide for the Treatment of Patients with Histologically Confirmed Stage D2 Prostate Cancer |
12/15/1989 |
9/15/1994 |
100% |
|
Published
|
| Closed |
SWOG-7814 |
A Comparison of Methotrexate and Cis-Platinum for Patients with Advanced Squamous Cell Carcinoma of the Head and Neck Region |
6/8/1978 |
10/16/1979 |
|
|
Published
|
| Closed |
SWOG-9126 |
A Controlled Trial of Cyclosporine as a Chemotherapy- Resistance Modifier in High Risk Acute Myeloid Leukemia, Phase III |
3/1/1993 |
3/1/1998 |
100% |
|
Published
|
| Closed |
SWOG-9032 |
A Controlled Trial of Cyclosporine As A Chemotherapy-Resistance Modifier in Blast Phase-Chronic Myelogenous Leukemia |
6/1/1992 |
3/1/1998 |
100% |
|
Published
|
| Closed |
SWOG-9031 |
A Double Blind Placebo Controlled Trial of Daunomycin and Cytosine Arabinoside With or Without rhG-CSF in Elderly Patients With Acute Myeloid Leukemia |
11/15/1991 |
1/15/1995 |
100% |
|
Published
|
| Closed |
S9617 |
A Phase I Study of PSC833 As Chemotherapy – Resistance Modifier in Patients Over Age 55 With Previously Untreated Myeloid Leukemia (AML). |
11/1/1996 |
9/1/1998 |
100% |
|
Published
|
| Closed |
SWOG-8940 |
A Phase I Study of the Combination of Recombinant Human Interleukin 1-Beta, Etoposide, and Carboplatin in Patients with Metastatic Cancer |
3/1/1990 |
11/1/1992 |
100% |
|
Published
|
| Closed |
SWOG-9026 |
A Phase I, Open Label, Multicenter Study of the Safety, Tolerability and Biological Effects of SDZ ILE 964 (Recombinant Human Interleukin-3), Administered to Patients with Metastatic Cancer Prior to… |
7/15/1991 |
9/29/1992 |
100% |
|
Published
|
| Closed |
SWOG-9436 (NABTC-9403) (NCI T94-0184) |
A Phase I/II Trial of Paclitaxel (Taxol®) Chemotherapy for Recurrent Malignant Glioma |
4/18/1995 |
2/4/1998 |
95% |
|
Published
|
| Closed |
SWOG-9006 |
A Phase II 19F Magnetic Resonance Spectroscopy (MRS) Study of 5-FU and Correlation with Clinical Results of 5-FU/Leucovorin (LV) Therapy in Patients with Carcinomas of the Gastrointestinal Tract |
10/15/1990 |
11/1/1996 |
77% |
|
Published
|
| Closed |
SWOG-9246 |
A Phase II Evaluation of Taxol in Patients with Relapsed Non-Hodgkin's Lymphoma |
3/1/1993 |
12/1/1995 |
58% |
|
Published
|
| Closed |
SWOG-8900 |
A Phase II Pilot of VAD and VAD/Verapamil for Refractory Multiple Myeloma |
5/1/1989 |
12/1/1991 |
100% |
|
Published
|
| Closed |
SWOG-9107 |
A Phase II Pilot Study of High Dose 24-Hour Continuous Infusion 5-FU and Leucovorin and Low-Dose PALA for Patients with Colorectal Cancer |
1/1/1993 |
8/1/1994 |
70% |
|
Published
|
| Closed |
SWOG-9100 |
A Phase II Pilot Study of High-Dose 24 Hour Continuous Infusion 5-FU and Leucovorin and Low-Dose PALA in Patients with Pancreatic Adenocarcinoma |
1/15/1993 |
8/1/1994 |
86% |
|
Published
|
| Closed |
SWOG-9500 |
A Phase II Study of 7 + 3 and High Dose Ara-C Induction Therapy with Sequential High-Dose Ara-C Consolidation Therapy for Adults with De Novo Acute Myeloid Leukemia |
12/15/1995 |
4/1/1997 |
100% |
|
Published
|
| Closed |
SWOG-9143 |
A Phase II Study of Cisplatin Preceded by a 12-hour Continuous Infusion of Concurrent Hydroxyurea and Cytosine Arabinoside (Ara-C) for Patients with Untreated Malignant Mesothelioma |
8/15/1992 |
9/15/1994 |
100% |
|
Published
|
| Closed |
SWOG-8824 |
A Phase II Study of Continuous Infusion Recombinant Interleukin-2 (rIL-2) in Patients with Advanced Renal Cell Carcinoma |
5/1/1989 |
8/15/1991 |
100% |
|
Published
|
